Stocksigma LogoStocksigma Logo

USFDA Concludes Inspection with VAI Classification for Dr. Reddy's Bachupally Facility

Dr. Reddy鈥檚 Laboratories announced that the USFDA has classified the Good Manufacturing Practices (GMP) inspection outcome at its formulations

USFDA Concludes Inspection with VAI Classification for Dr. Reddy's Bachupally Facility

Dr Reddys Laboratories Ltd 路 Others (Uncategorized) 路 14 Nov 2026, 10:20 pm

USFDA Concludes Inspection with VAI Classification for Dr. Reddy's Bachupally Facility Dr. Reddy鈥檚 Laboratories announced that the USFDA has classified the Good Manufacturing Practices (GMP) inspection outcome at its formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad, as Voluntary Action Indicated (VAI). Following the inspection previously disclosed on 14th Aug'26, the USFDA has officially concluded and closed the inspection under 21 CFR 20.64(d)(3), removing regulatory overhang for the manufacturing unit.

Original exchange filing (PDF)

More announcements from Dr Reddys Laboratories Ltd

All Dr Reddys Laboratories Ltd announcements